BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 12181718)

  • 1. Expression of somatostatin receptor and effects of somatostatin analog on pancreatic endocrine tumors.
    Oda Y; Tanaka Y; Naruse T; Sasanabe R; Tsubamoto M; Funahashi H
    Surg Today; 2002; 32(8):690-4. PubMed ID: 12181718
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Octreotide in insulinoma patients: efficacy on hypoglycemia, relationships with Octreoscan scintigraphy and immunostaining with anti-sst2A and anti-sst5 antibodies.
    Vezzosi D; Bennet A; Rochaix P; Courbon F; Selves J; Pradere B; Buscail L; Susini C; Caron P
    Eur J Endocrinol; 2005 May; 152(5):757-67. PubMed ID: 15879362
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Usefulness of the octreotide test in Japanese patients for predicting the presence/absence of somatostatin receptor 2 expression in insulinomas.
    Nakamura A; Mitsuhashi T; Takano Y; Miyoshi H; Kameda H; Nomoto H; Nagai S; Hatanaka Y; Shimizu C; Terauchi Y; Atsumi T
    Endocr J; 2016; 63(2):135-42. PubMed ID: 26567922
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complete clinical remission and disappearance of liver metastases after treatment with somatostatin analogue in a 40-year-old woman with a malignant insulinoma positive for somatostatin receptors type 2.
    Romeo S; Milione M; Gatti A; Fallarino M; Corleto V; Morano S; Baroni MG
    Horm Res; 2006; 65(3):120-5. PubMed ID: 16479142
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Presence of somatostatin receptors negatively coupled to adenylate cyclase in ectopic growth hormone-releasing hormone- and alpha-subunit-secreting tumors from acromegalic patients responsive to octreotide.
    Bertherat J; Turpin G; Rauch C; Li JY; Epelbaum J; Sassolas G; Schaison G
    J Clin Endocrinol Metab; 1994 Nov; 79(5):1457-64. PubMed ID: 7962343
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Somatostatin analog inhibits the growth of insulinoma cells by p27-mediated G1 cell cycle arrest.
    Aoki T; Motoi F; Sakata N; Naitoh T; Katayose Y; Egawa S; Miyazaki J; Unno M
    Pancreas; 2014 Jul; 43(5):720-9. PubMed ID: 24694834
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Therapy of endocrine gastrointestinal-pancreatic tumors with somatostatin analog octreotide].
    Arnold R; Neuhaus C; Trautmann ME
    Dtsch Med Wochenschr; 1992 Jul; 117(27):1067-71. PubMed ID: 1352235
    [No Abstract]   [Full Text] [Related]  

  • 8. Somatostatin receptors 2 and 5 are the major somatostatin receptors in insulinomas: an in vivo and in vitro study.
    Bertherat J; Tenenbaum F; Perlemoine K; Videau C; Alberini JL; Richard B; Dousset B; Bertagna X; Epelbaum J
    J Clin Endocrinol Metab; 2003 Nov; 88(11):5353-60. PubMed ID: 14602773
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of treatment with depot somatostatin analogue octreotide on primary hyperparathyroidism (PHP) in multiple endocrine neoplasia type 1 (MEN1) patients.
    Faggiano A; Tavares LB; Tauchmanova L; Milone F; Mansueto G; Ramundo V; De Caro ML; Lombardi G; De Rosa G; Colao A
    Clin Endocrinol (Oxf); 2008 Nov; 69(5):756-62. PubMed ID: 18485119
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of somatostatin receptor subtypes and an implication for the efficacy of somatostatin analogue SMS 201-995 in treatment of human endocrine tumors.
    Kubota A; Yamada Y; Kagimoto S; Shimatsu A; Imamura M; Tsuda K; Imura H; Seino S; Seino Y
    J Clin Invest; 1994 Mar; 93(3):1321-5. PubMed ID: 8132773
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Somatostatin receptors in gastroentero-pancreatic neuroendocrine tumours.
    de Herder WW; Hofland LJ; van der Lely AJ; Lamberts SW
    Endocr Relat Cancer; 2003 Dec; 10(4):451-8. PubMed ID: 14713257
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of somatostatin analogs in the treatment of endocrine gastrointestinal tumors.
    Trautmann ME; Neuhaus C; Lenze H; Benning R; Benning M; Dennler HJ; Bruns C; Joseph K; Arnold R
    Horm Metab Res Suppl; 1993; 27():24-7. PubMed ID: 8392487
    [No Abstract]   [Full Text] [Related]  

  • 13. In vitro and in vivo detection of functional somatostatin receptors in canine insulinomas.
    Robben JH; Visser-Wisselaar HA; Rutteman GR; van Rijk PP; van Dongen AJ; Voorhout G; van den Ingh TS; Hofland LJ; Lamberts SW
    J Nucl Med; 1997 Jul; 38(7):1036-42. PubMed ID: 9225787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Somatostatin and somatostatin analogues: diagnostic and therapeutic uses.
    de Herder WW; Lamberts SW
    Curr Opin Oncol; 2002 Jan; 14(1):53-7. PubMed ID: 11790981
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of somatostatin receptor subtypes 1 to 5 in tumor tissue and intratumoral vessels in malignant endocrine pancreatic tumors.
    Fjällskog ML; Ludvigsen E; Stridsberg M; Oberg K; Eriksson B; Janson ET
    Med Oncol; 2003; 20(1):59-67. PubMed ID: 12665686
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential regulation of somatostatin receptor type 2 (sst 2) expression in AR4-2J tumor cells implanted into mice during octreotide treatment.
    Froidevaux S; Hintermann E; Török M; Mäcke HR; Beglinger C; Eberle AN
    Cancer Res; 1999 Aug; 59(15):3652-7. PubMed ID: 10446977
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Somatostatin analogs in the management of gastrointestinal tumors.
    Lamberts SW
    Horm Res; 1988; 29(2-3):118-20. PubMed ID: 2900191
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Internalized somatostatin receptor subtype 2 in neuroendocrine tumors of octreotide-treated patients.
    Reubi JC; Waser B; Cescato R; Gloor B; Stettler C; Christ E
    J Clin Endocrinol Metab; 2010 May; 95(5):2343-50. PubMed ID: 20228164
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dissociation between the effects of somatostatin (SS) and octapeptide SS-analogs on hormone release in a small subgroup of pituitary- and islet cell tumors.
    Hofland LJ; De Herder WW; Visser-Wisselaar HA; Van Uffelen C; Waaijers M; Zuyderwijk J; Uitterlinden P; Kros MJ; Van Koetsveld PM; Lamberts SW
    J Clin Endocrinol Metab; 1997 Sep; 82(9):3011-8. PubMed ID: 9284735
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Indirect antiproliferative effect of the somatostatin analog octreotide on MIA PaCa-2 human pancreatic carcinoma in nude mice.
    Weckbecker G; Raulf F; Bodmer D; Bruns C
    Yale J Biol Med; 1997; 70(5-6):549-54. PubMed ID: 9825482
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.